Detalles de la búsqueda
1.
Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients.
Blood
; 141(9): 1036-1046, 2023 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096473
2.
Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia.
Haematologica
; 109(1): 163-174, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439335
3.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439329
4.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Hematol Oncol
; 42(4): e3290, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38818978
5.
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Ann Hematol
; 103(1): 125-132, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731147
6.
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience.
Ann Hematol
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805036
7.
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis.
Haematologica
; 108(3): 833-842, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36200419
8.
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
Hematol Oncol
; 39(1): 41-50, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085797
9.
Identification of a miR-146b-Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia.
Haematologica
; 105(5): 1351-1360, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31467122
10.
Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
Ann Hematol
; 98(3): 679-689, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30539276
11.
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study.
Br J Haematol
; 186(3): e13-e17, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30854624
12.
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.
Haematologica
; 99(12): 1826-33, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25193965
13.
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders.
Blood Cancer J
; 14(1): 13, 2024 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38238319
14.
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Cancer Med
; 13(7): e7071, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558233
15.
Not all LGL leukemias are created equal.
Blood Rev
; 60: 101058, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36870881
16.
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma.
Front Oncol
; 12: 851864, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35359355
17.
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma.
Cancers (Basel)
; 14(17)2022 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077711
18.
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation.
Nat Commun
; 13(1): 3298, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35676278
19.
Identification of novel STAT5B mutations and characterization of TCRß signatures in CD4+ T-cell large granular lymphocyte leukemia.
Blood Cancer J
; 12(2): 31, 2022 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35210405
20.
Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf.
Pharmaceuticals (Basel)
; 14(1)2021 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33430210